Form 4 for NRXS Neuraxis, INC
Accepted 2026-01-30 00:00:00 ET · period of report 2026-01-22 · accession 0001493152-26-004590 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-30 | 2026-01-22 | NRXS | Aharon Gil | Dir | A - Grant | $4.63 | +21.6K | 307.7K | +8% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-01-22 | A | A | 21,598 | $4.63 | 307,736 | D | — | — | (F2) 21,598 shares of common stock were issued to the Reporting Person as compensation for services as independent director of the Issuer. (F1) Includes (1) 286,138 shares of common stock owned by Rosalind Master Fund L.P., and (2) 21,598 shares of common stock issued to the Reporting Person as compensation for services as an independent director of the Issuer. |